<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000535471">
  <TermName>Exjade</TermName>
  <TermPronunciation>(EX-jayd)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used to treat too much iron in the blood caused by blood transfusions. It is being studied in the treatment of myelodysplastic syndromes (a group of diseases in which the bone marrow does not make enough healthy blood cells) and other conditions. Exjade binds to extra iron in the blood. The drug and the iron are passed from the body in urine. It is a type of chelating agent. Also called deferasirox.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000718379" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Exjade&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000718378" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Exjade&quot;" language="es" id="_4"/>
  <SpanishTermName>Exjade</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento usado para tratar el exceso de hierro en la sangre causado por transfusiones de sangre. Está en estudio para el tratamiento de los síndromes mielodisplásicos (grupo de enfermedades en las que la médula ósea no produce suficientes células sanguíneas sanas) y otras afecciones. Exjade se une al hierro extra en la sangre. El medicamento y el hierro salen del cuerpo con la orina. Es un tipo de quelante. También se llama deferasirox.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2007-02-12</DateFirstPublished>
  <DateLastModified>2007-09-21</DateLastModified>
</GlossaryTerm>
